Prognostic value of CAF marker expression in the intratumoral and marginal areas of soft tissue sarcoma
Pathobiology · 2024
DOI: 10.1159/000539855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, 2024. Verfasst von Michinobu Umakoshi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Akita, Japan. Hauptthemen laut MEDLINE: Sarcoma, Biomarkers, Tumor, Cancer-Associated Fibroblasts, Soft Tissue Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The tumor microenvironment of sarcomas has not been studied in detail; in particular, little is known about cancer-associated fibroblasts (CAFs). Sarcoma cells are difficult to distinguish from CAFs, either histomorphologically or immunohistochemically.
Methods
We scored expression of individual CAF markers (fibroblast activating protein (FAP), CD10, and podoplanin) in the intratumoral and marginal areas of 133 sarcomas. We also examined the association between these markers, as well as the number of CD163-positive macrophages (i.e., tumor-associated macrophages), and clinical outcome.
Results
In all cases, the log-rank test revealed that those with high marker scores and macrophage counts (except for marginal CD10+ CAFs) showed significantly worse disease-free survival (DFS). Grade 2/3 cases with high CAF scores (excluding the marginal FAP and CD10 scores) showed significantly worse DFS, whereas those with high intratumoral FAP/CD10 and marginal podoplanin scores showed significantly worse metastasis-free survival (MFS), and those with a high intratumoral CD10 score showed significantly worse local recurrence-free survival (LFS). Multivariate analysis identified intratumoral CD10/podoplanin scores and marginal FAP/podoplanin scores as independent prognostic factors for DFS, intratumoral FAP/CD10 and marginal FAP/podoplanin/CD163-positive macrophage scores as independent prognostic factors for MFS, and the intratumoral podoplanin score as an independent prognostic factor for LFS. There was a weak-to-moderate correlation between each score and CD163-positive macrophage counts.
Conclusion
Patients with high CAF marker expression in the intratumoral and marginal areas have a poorer outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
- Department of Pathology, Akita University Hospital, Akita, Japan.
- Department of Physical Therapy, Akita University Graduate School of Health Science, Akita, Japan.
- Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Zitieren
APA
Umakoshi, M., Kudo-Asabe, Y., Tsuchie, H., Li, Z., Koyama, K., Miyabe, K., Yoshida, M., Nagasawa, H., Nanjo, H., Okada, K., Maeda, D., Miyakoshi, N., Tanaka, M., & Goto, A. (2024). Prognostic value of CAF marker expression in the intratumoral and marginal areas of soft tissue sarcoma. Pathobiology. https://doi.org/10.1159/000539855
Vancouver
Umakoshi M, Kudo-Asabe Y, Tsuchie H, Li Z, Koyama K, Miyabe K, et al. Prognostic value of CAF marker expression in the intratumoral and marginal areas of soft tissue sarcoma. Pathobiology. 2024. doi:10.1159/000539855
BibTeX
@article{Umakoshi2024,
author = {Umakoshi, Michinobu and Kudo-Asabe, Yukitsugu and Tsuchie, Hiroyuki and Li, Zhuo and Koyama, Kei and Miyabe, Ken and Yoshida, Makoto and Nagasawa, Hiroyuki and Nanjo, Hiroshi and Okada, Kyoji and Maeda, Daichi and Miyakoshi, Naohisa and Tanaka, Masamitsu and Goto, Akiteru},
title = {Prognostic value of CAF marker expression in the intratumoral and marginal areas of soft tissue sarcoma},
journal = {Pathobiology},
year = {2024},
doi = {10.1159/000539855}
}
EUVIMED